Skip to main content

Table 2 30-day mortality and time to death according to primary discharge diagnoses

From: Mortality of older acutely admitted medical patients after early discharge from emergency departments: a nationwide cohort study

Discharge diagnoses

Mortality

N (%; 95% CI)

Time to death, median days (IQR)

Diseases of the cardiovascular system

 Angina pectoris (n = 1901)

11 (0.6; 0.3–1.0)

16 (11–22)

 Atrial fibrillation (n = 7187)

59 (0.8; 0.6–1.1)

15 (8–22)

 Deep vein thrombosis (n = 1324)

18 (1.4; 0.8–2.1)

14.5 (9–26)

 Hypertension (n = 1622)

7 (0.4; 0.2–0.9)

9 (7–22)

 Heart failure (1004)

61 (6.1; 4.7–7.7)

10 (6–18)

Diseases of the respiratory system

 COPD (n = 3088)

111 (3.6; 3.0–4.3)

14 (6–21)

 Respiratory failure (n = 564)

60 (10.6; 8.2–13.5)

7 (1–14)

Diseases of the nervous system

 TIA (n = 1441)

13 (0.9; 0.5–1.5)

21 (17–25)

 Epilepsy (n = 650)

5 (0.8; 0.3–1.8)

13 (12–16)

Endocrine and nutritional diseases

 Diabetes (n = 598)

23 (3.9; 2.5–5.7)

18 (8–25)

 Dehydration (n = 2167)

231 (10.7; 9.4–12.0)

12 (6–19)

Diseases of the digestive system

 Dyspepsia (n = 358)

NA

NA

 Esophagitis (n = 53)

NA

NA

 Constipation (1502)

66 (4.4; 3.4–5.6)

18 (9–24)

 Ulcer without bleeding (n = 49)

NA

NA

Hematological diseases

 Anemia (n = 4168)

240 (5.8; 5.1–6.5)

18 (11–25)

Infectious disease

 Erysipelas (n = 769)

14 (1.8; 1.0–3.0)

14.5 (3–25)

 Gastroenteritis (n = 652)

10 (1.5; 0.7–2.8)

7 (6–9)

 Pneumonia (n = 2711)

197 (7.3; 6.3–8.3)

11 (5–19)

 Urinary Tract Infection (n = 3468)

174 (5.0; 4.3–5.8)

14 (7–22)

Spinal disease/arthritis

 Back Pain (n = 1028)

19 (1.8; 1.1–2.9)

14 (6–25)

 Arthritis (n = 166)

NA

NA

Mental and behavioral disorders

 Misuse of drugs or alcohol (n = 1078)

26 (2.4; 1.6–3.5)

14.5 (7–22)

R-diagnosesa

 Chest pain (n = 4157)

36 (0.9; 0.6–1.2)

14.5 (822.5)

 Dyspnea (n = 2450)

133 (5.4; 4.6–6.4)

13 (7–21)

 Fever (n = 688)

20 (2.9; 1.8–4.5)

10.5 (4–19.5)

 Headache (n = 569)

3 (0.5; 0.1–1.5)

15 (11–17)

 Pains in neuromuscular system (n = 1035)

25 (2.4; 1.6–3.6)

14 (5–26)

 Abdominal pain (n = 4916)

116 (2.4; 2.0–2.8)

16 (9–23)

 Other pain (n = 1246)

48 (3.9; 2.9–5.1)

12.5 (5.5–21.5)

 Vertigo (n = 1984)

18 (0.9; 0.5–1.4)

15.5 (8–23)

 Other R-diagnoses (n = 10,822)

440 (4.1; 3.7–4.5)

15 (7–23)

Z-diagnosesb

 Malignancy (n = 1526)

75 (4.9; 3.9–6.1)

21 (10–26)

 Central-nervous diseases (n = 1841)

44 (2.4; 1.7–3.2)

14 (6–22)

 Heart diseases (n = 3297)

30 (0.9; 0.6–1.3)

19.5 (10–25)

 Myocardial infarction (n = 5705)

43 (0.8; 0.6–1.0)

17 (8–23)

 Rehabilitation (8035)

227 (2.8; 2.5–3.2)

11 (1–29)

 Other Z-diagnoses (n = 3986)

123 (3.1; 2.6–3.7)

11 (6–20)

  1. CI confidence interval, COPD chronic obstructive pulmonary disease, IQR interquartile range, NA not available (data not presented when there are less than 5 events in the group due to privacy concerns), TIA transient ischemic attack
  2. aUsed if symptoms, signs and abnormal clinical and laboratory findings are not elsewhere classified. bUsed when a diagnosis has not yet been confirmed